Ongoing treatment(s)-Radiation Posts on Medivizor
Navigation Menu

Ongoing treatment(s)-Radiation Posts on Medivizor

How long should patients with locally advanced rectal cancer wait between chemoradiotherapy and surgery to achieve the best outcome?

How long should patients with locally advanced rectal cancer wait between chemoradiotherapy and surgery to achieve the best outcome?

Posted by on Feb 26, 2021 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the timing between chemoradiotherapy (CRT) and surgery in patients with locally advanced rectal cancer (LARC). The study found that patients who had surgery more than 10 weeks after CRT had the best outcome. Some background Rectal cancer is commonly treated with surgery to remove the tumor. LARC is...

Read More

Evaluating the effects of radiation doses on erectile function in localized prostate cancer treated with permanent prostate brachytherapy.

Evaluating the effects of radiation doses on erectile function in localized prostate cancer treated with permanent prostate brachytherapy.

Posted by on Jan 31, 2021 in Prostate cancer | 0 comments

In a nutshell This study investigated the relationship between radiation doses in prostate brachytherapy (BT) and erectile function reduction in patients with localized prostate cancer (PCa). The data showed that sexual function decreased over time with higher doses of BT. Some background Localized prostate cancer (PCa) is a form of cancer that...

Read More

Should patients with prostate cancer get androgen deprivation therapy before or after radiotherapy?

Should patients with prostate cancer get androgen deprivation therapy before or after radiotherapy?

Posted by on Dec 20, 2020 in Prostate cancer | 0 comments

In a nutshell This study compared the effectiveness of giving androgen deprivation therapy (ADT) before or after radiotherapy (RT) for prostate cancer (PCa). The study found that treatment with RT followed by ADT increased patient survival without the spread of the disease. Some background PCa can often spread to other locations within the...

Read More

Looking for patients with stage III non-small cell lung cancer to trial a treatment combination with radiotherapy

Looking for patients with stage III non-small cell lung cancer to trial a treatment combination with radiotherapy

Posted by on Aug 23, 2020 in Lung cancer | 0 comments

In a nutshell This study is looking to examine the effectiveness of durvalumab (Imfinzi) and consolidation stereotactic body radiation therapy (SBRT) after chemoradiation for locally advanced stage III non-small-cell lung cancer (NSCLC). The main outcomes to be measured are the occurrence of side effects and the survival without cancer...

Read More

Does anti-clotting medication improve treatment results for patients with prostate cancer?

Does anti-clotting medication improve treatment results for patients with prostate cancer?

Posted by on Jun 6, 2020 in Prostate cancer | 0 comments

In a nutshell This study examined if lower numbers of platelets (blood cells involved in forming clots) and anti-clotting medications were associated with treatment results in patients with prostate cancer (PC). The authors found that lower numbers of platelets and anti-clotting medication were associated with higher treatment...

Read More

Can bowel side effects caused by radiotherapy be reduced by a spacer tool in patients with prostate cancer?

Can bowel side effects caused by radiotherapy be reduced by a spacer tool in patients with prostate cancer?

Posted by on May 30, 2020 in Prostate cancer | 0 comments

In a nutshell This study examined if a hydrogel spacer tool improved long-term quality of life for patients with prostate cancer (PC) who received radiotherapy (RT). The results showed that the spacer significantly reduced bowel side effects and improved patients’ quality of life. Some background RT is an effective therapy for patients with...

Read More

How long should hormonal treatment be given to patients with locally advanced prostate cancer?

Posted by on Apr 14, 2020 in Prostate cancer | 0 comments

In a nutshell This study compared 6-month and 18-month courses of hormonal anti-androgen treatment and radiotherapy (RT) in patients with locally advanced prostate cancer (LAPC). The results showed that 18-month treatment was most effective, especially when used with high dose brachytherapy RT. Some background Androgens (such as testosterone) are...

Read More

Should additional chemotherapy be added to chemoradiotherapy in patients with inoperable non-small cell lung cancer?

Posted by on Oct 20, 2019 in Lung cancer | 0 comments

In a nutshell This study examined how effective additional chemotherapy alongside chemo-radiotherapy is in patients with locally advanced non-small cell lung cancer. The study found that additional chemotherapy did not bring survival benefits in these patients. Some background Non-small cell lung cancer (NSCLC) can be difficult to treat. There are a...

Read More

MRI prognostic parameters in tailoring treatment for locally advanced rectal cancer

Posted by on Aug 31, 2019 in Colorectal cancer | 0 comments

In a nutshell This study investigated the use of MRI predictive results to decide the best treatment for patients with locally advanced rectal cancer (LARC). Researchers suggested that early MRI results should be used in the treatment decision making. Some background Colorectal cancer is the third most common cancer in the world. Patients with LARC...

Read More

Looking for patients with lung cancer to test a new immunotherapy combination

Posted by on Apr 24, 2019 in Lung cancer | 0 comments

In a nutshell This phase 1/2 trial is examining the effectiveness of durvalumab (Imfinzi) and monalizumab to treat patients with solid tumors, including lung cancer. The main outcomes to be measured are tumor response to the treatment and side effects. The details Cancer is one of the leading causes of death worldwide. Chemotherapy is only of limited...

Read More